James David Clark, SVP, Cont & Chief Acct Officer at CVS HEALTH Corp (CVS), sold 270 shares at $65.00 ($18K) on 2020-05-26, disclosed to the SEC on 2020-05-28.
Scheduled sale ($18k) by SVP, Cont & Chief Acct Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CVS | SELL | 2022-02-01 | $660K | — | Filing → |
| CVS | SELL | 2021-04-01 | $407K | — | Filing → |
| CVS | SELL | 2020-04-30 | $405K | — | Filing → |